Dividends Calendar Earnings Calendar
ICPT

ICPT | Intercept Pharma

Intercept Pharma
Category: Company
  • Industry: Drug Manufacturers - Major

Quick infos

  • Headquarters:   United States of America

Trade prices

  • Volume:
  • Market Cap: 472.11M
  • Prev closed: 39.65
  • Open: 39.9
  • High: 40.41
  • Low: 38.96
  • 52 week low: 38.96
  • 52 week high: 125
  • Dividends:No Dividends

Next ER: May 6, 2022 



Top Stories (ICPT)

    About the Company

    Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 3, 2022
    May 6, 2022-0.58 / -0.924188.58M / 90.42M
    March 2, 2022-1.23 / -1.0492.4M / 92.39MBeat!
    November 3, 2021-0.11 / -1.192.83M / 83.04MBeat!
    July 29, 2021-0.33 / -1.2296.58M / 82.68MBeat!
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    May 5, 2022 19.59 18.75
    20.00
    17.35
    14.36M 21%
    May 4, 2022 16.19 15.78
    16.41
    14.91
    642.67K 2.40%
    May 3, 2022 15.81 16.09
    16.45
    15.44
    487.56K -1.25%
    May 2, 2022 16.01 15.63
    16.44
    15.22
    550.79K 1.91%
    Apr 29, 2022 15.71 15.74
    16.27
    15.64
    736.01K -1.19%
    Apr 28, 2022 15.90 15.86
    16.07
    15.13
    446.28K 1.40%
    Apr 27, 2022 15.68 15.64
    15.98
    15.41
    448.76K 0%
    Apr 26, 2022 15.68 16.55
    16.81
    15.53
    878.43K -6.28%
    Apr 25, 2022 16.73 15.96
    16.87
    15.96
    370.58K 2.76%
    Apr 22, 2022 16.28 15.77
    16.40
    15.77
    486.04K 2.71%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2002
    • Employees:456

    News

    News for (ICPT)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Mark E. Pruzanski, MD
    • Chief Human Resources Officer :  David Ford

    Talk about Intercept Pharma below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 6, 2022 (Same day)

    mmi icpt gt clmt brk.b ua ci iep glp nrg esnt lsxma 


    Jump to (Finance sites)

    Their Official Profiles 

    WikipediaTwitterLinkedIn

    Peers / Similar stocks 

    xlv gild lly bmy 

    Other stocks 

    mcd snap jnj fb t ual bac low vfc xlnx dwdp five 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet